Michael P Blair to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Michael P Blair has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.699
-
In reply to Mireskandari and coworkers. JAMA Ophthalmol. 2013 Apr; 131(4):546-7.
Score: 0.304
-
Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization in ocular histoplasmosis. Retin Cases Brief Rep. 2014; 8(1):24-9.
Score: 0.080
-
Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab. J AAPOS. 2013 Jun; 17(3):323-5.
Score: 0.076
-
Reactivation of retinopathy of prematurity after bevacizumab injection. Arch Ophthalmol. 2012 Aug; 130(8):1000-6.
Score: 0.073
-
Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity. Arch Ophthalmol. 2012 Jun; 130(6):801-2.
Score: 0.072
-
Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment. Arch Ophthalmol. 2010 Aug; 128(8):1080-1.
Score: 0.063
-
Acquired vasoproliferative retinal tumor: a late sequela of retinopathy of prematurity. Arch Ophthalmol. 2011 Sep; 129(9):1234-5.
Score: 0.017
-
Intravitreal bevacizumab for neovascular glaucoma. J Ocul Pharmacol Ther. 2009 Oct; 25(5):453-8.
Score: 0.015